Morten Karsdal

Company: Nordic Biosciences

Job title: Chief Executive Officer


ECM Remodeling is the Key Common Denominator in all Fibrotic Diseases: Serological Quantification of Fibrogenesis and Fibrosis Resolution Separately Reveals Treatable Endotypes 11:15 am

• Establishing that fibrosis may develop from both excessive tissue formation and decreased degradation and organ failure as a consequence of collagen accumulation • Identifying different treatable endotypes in fibrotic disease • Exploring that some collagens are needed for specialized cell function, while others are dangerousRead more

day: Day One

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.